GSK5458514
/ GSK
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 30, 2025
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
(clinicaltrials.gov)
- P1/2 | N=82 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting
Enrollment open • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
May 27, 2025
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostrate Cancer
(clinicaltrials.gov)
- P1/2 | N=82 | Not yet recruiting | Sponsor: GlaxoSmithKline
New P1/2 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1